Immuron (IMRN) Net Cash Flow (2016 - 2024)
Immuron (IMRN) recorded quarterly Net Cash Flow of -$2.6 million in Q4 2024, down 113.47% quarter-over-quarter from -$1.2 million in Q4 2023, and down 113.47% on a YoY basis from $19.3 million in Q1 2024.
Immuron (IMRN) Net Cash Flow (2016 - 2024) Analysis & Trends
Immuron's Net Cash Flow history runs 9 years deep, the most recent figure standing at -$2.6 million for Q4 2024.
- In Q4 2024, Net Cash Flow fell 113.47% year-over-year to -$2.6 million; the TTM figure through Sep 2025 stood at -$2.6 million (down 113.47% YoY), while the FY2025 annual figure was -$8.8 million, down 59.19% from the prior year.
- Net Cash Flow was -$2.6 million for Q4 2024 at Immuron, down from -$1.2 million in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $23.9 million in Q4 2020 to a low of -$2.6 million in Q4 2024.
- Historically, Net Cash Flow has averaged $3.6 million across 5 years, with a median of -$1.2 million in 2023.
- The sharpest annual moves came in 2020 and 2023: Net Cash Flow jumped 8005.28% in 2020, then slumped 91905.13% in 2023.
- A 5-year view of Net Cash Flow shows it stood at $23.9 million in 2020, then plunged by 108.27% to -$2.0 million in 2021, then jumped by 100.07% to $1328.5 in 2022, then plunged by 91905.13% to -$1.2 million in 2023, then sank by 113.47% to -$2.6 million in 2024.
- The last three Net Cash Flow figures came in at -$2.6 million (Q4 2024), -$1.2 million (Q4 2023), and $1328.5 (Q4 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 625.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.44 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 457.40 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 664,983.53 |
| 10 | Immuron | 921.61 Mn | 921.58 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -2.60 Mn |
| Dec 31, 2024 | -2.60 Mn |
| Dec 31, 2023 | -1.22 Mn |
| Dec 31, 2023 | -1.22 Mn |
| Dec 31, 2022 | 1,328.50 |
| Dec 31, 2022 | 1,328.50 |
| Dec 31, 2021 | -1.98 Mn |
| Dec 31, 2021 | -1.98 Mn |
| Dec 31, 2020 | 23.89 Mn |
| Dec 31, 2020 | 23.89 Mn |
| Dec 31, 2019 | -302,214.00 |
| Dec 31, 2019 | -302,214.00 |
| Dec 31, 2018 | -424,901.00 |
| Dec 31, 2018 | -424,901.00 |
| Dec 31, 2017 | -2.68 Mn |
| Dec 31, 2017 | -2.68 Mn |
| Dec 31, 2016 | 3.96 Mn |
| Dec 31, 2016 | 3.96 Mn |